House Passes Insulin Price Cap as Senate Looks for Path Forward

The U.S. House Thursday passed a bill to cap what insured Americans pay for insulin, moving forward a key component of President Joe Biden’s drug pricing agenda.

Lawmakers voted 232-193 in favor of a modified version of the bill (H.R. 6833). Its future remains uncertain for now as a group of senators work to craft a separate insulin proposal that could achieve bipartisan support.

The House bill would limit out-of-pocket costs under private health insurance and Medicare to $35 for a month’s supply of selected insulin products or 25% of a plan’s negotiated price, whichever is less. It ...